Discover 2,314 paid clinical trials in Oceanside, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,314
FeaturedActive & Responsive
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
for
Moderately to Severely Active Crohns Disease
Location: La Jolla CA, San Diego CA, Garden Grove CA,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 16 - 70+
Code: NCT06819878
Phase3, Recruiting
FeaturedActive & Responsive
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer
for
Metastatic Breast Cancer
Location: La Jolla CA, Irvine CA, Duarte CA, Los Angeles CA,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT03424005
Phase1, Phase2, Recruiting
FeaturedActive & Responsive
A Study to Evaluate Safety, Pharmacokinetics, and Activity of GDC-7035 as a Single Agent and in Combination in Patients With Advanced Solid Tumors
for
Solid Tumor
Location: La Jolla CA, Vancouver, Dallas PA, Houston TX,
Sponsor: Genentech, Inc.
Sex: All
Age: 18+
Code: NCT06619587
Phase1, Recruiting
FeaturedActive & Responsive
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative Colitis
for
Moderately to Severely Active Ulcerative Colitis
Location: Newport Beach CA, Garden Grove CA, Los Angeles CA,
Get alerts for new trials in your area by subscribing now
Featured
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
for
Chronic Migraine
Location: Oceanside CA, Anaheim CA, Long Beach CA, Fresno CA,
Sponsor: AbbVie
Sex: All
Age: 12 - 17
Code: NCT06810505
Phase3, Recruiting
Featured
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
for
Migraine
Location: Oceanside CA, San Diego CA, Anaheim CA, La Palma CA,
Sponsor: AbbVie
Sex: All
Age: 6 - 17
Code: NCT05125302
Phase3, Recruiting
Featured
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
for
Breast Cancer
Location: San Marcos CA, La Jolla CA, Irvine CA, Los Alamitos CA,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT06790693
Phase3, Recruiting
Featured
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Location: Escondido CA, Poway CA, La Jolla CA, Coronado CA,
Sponsor: 89bio, Inc.
Sex: All
Age: 18 - 70+
Code: NCT06318169
Phase3, Recruiting
Featured
Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Participants With Diabetic Retinopathy Without Center-Involved Diabetic Macular Edema
for
Diabetic Retinopathy
Location: Poway CA, Torrance CA, Pasadena CA, Encino CA,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT07592273
Phase2, Phase3, Recruiting
Featured
Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)
for
Neovascular Age-related Macular Degeneration
Location: Poway CA, La Jolla CA, Newport Beach CA, Santa Ana CA,
Sponsor: AbbVie
Sex: All
Age: 50+
Code: NCT07007065
Phase3, Recruiting
Featured
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
for
Parkinson's Disease
Location: La Jolla CA, Fullerton CA, Los Angeles CA, Pasadena CA,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 50 - 70+
Code: NCT07174310
Phase3, Recruiting
Featured
A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
for
Non-Small Cell Lung Cancer
Location: La Jolla CA, Irvine CA, Duarte CA, Vancouver WA,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT07155187
Phase2, Phase3, Recruiting
Featured
A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer
for
Ovarian Cancer
Location: La Jolla CA, Eugene OR, Billings MT, Abilene TX,
Sponsor: AbbVie
Sex: Female
Age: 18+
Code: NCT07059845
Phase2, Recruiting
Featured
A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer
for
Breast Cancer
Location: La Jolla CA, San Diego CA, Irvine CA, Duarte CA,
Sponsor: Genentech, Inc.
Sex: All
Age: 18+
Code: NCT07100106
Phase1, Phase2, Recruiting
Featured
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Location: La Jolla CA, Poway CA, Coronado CA, Fountain Valley CA,
Sponsor: 89bio, Inc.
Sex: All
Age: 18 - 70+
Code: NCT06419374
Phase3, Recruiting
Featured
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
for
Ulcerative Colitis
Location: San Diego CA, Lancaster CA, Salt Lake City UT,
Sponsor: Genentech, Inc.
Sex: All
Age: 18+
Code: NCT06979336
Phase2, Recruiting
Featured
A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
for
Ulcerative Colitis
Location: San Diego CA, Phoenix AZ, San Francisco CA, Dallas TX,
Sponsor: AbbVie
Sex: All
Age: 2 - 17
Code: NCT07071519
Phase3, Recruiting
Featured
Study to Assess the Real-World Effectiveness of Ubrogepant in Adult Participants When Treating During the Prodrome Phase of Migraine Attacks
for
Migraine
Location: Aliso Viejo CA, Grand Island NE, Naperville IL
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT07310290
Recruiting
Featured
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
for
Epithelial Ovarian Cancer, Fallopian Tube Cancer,
Location: San Diego CA, Los Angeles CA, San Francisco CA, Reno NV,